Skip to the content
Healthcare Providers
  • Prescribing Information
  • Important Safety Information
TRILURONTRILURON
Healthcare Providers
  • Prescribing Information
  • Important Safety Information
  • About TRILURON®
  • Reimbursement
  • About Knee OA
  • Resources
  • About TRILURON®
  • Reimbursement
  • About Knee OA
  • Resources
  • HCP Site
  • Fidia Pharma USA Inc.
Easy Glider

Get long-lasting relief from osteoarthritis (OA)
knee pain with just 3 injections1

Indication

TRILURON® is used to relieve knee pain caused by osteoarthritis. It is used for patients who do not get adequate pain relief from simple pain relievers or from exercise and physical therapy.

Important Safety Information

Before receiving TRILURON®, tell your doctor if you are allergic to hyaluronan products or have an infection or skin disease in the area of the injection site. Tell your doctor if you think you are pregnant or if you are nursing a child or if you are allergic to bird proteins, feathers or egg products. TRILURON® is not approved for relieving pain in other joints besides the knee or for injection with other substances in your knee joint. TRILURON® has not been tested in pregnant or nursing women or children. The effectiveness of repeat treatment cycles has not been established. Injections must only be given by trained and licensed healthcare professionals. Talk to your doctor before resuming strenuous or prolonged weight-bearing activities after treatment.

The side effects most commonly seen after injection into the knee joint are knee pain, discomfort, swelling, fluid in the joint, warmth or redness at the injection site. These symptoms usually disappear within a few days by resting the injected knee and applying ice. Sometimes these side effects may be more severe and last longer. Signs of an allergic reaction many include rash, itching hives, flushing, swelling of your face, tongue or throat, difficulty breathing or swallowing and shortness of breath. If any of these symptoms or signs appear after you are injected, or if you have any other problems, contact your doctor. Please see package insert for full warnings, precautions, and possible side effects.

Rx Only.

Please see Full Patient Labeling.

www.TRILURON.com

  • Prescribing Information
  • Important Safety Information
  • References
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us
  • FidiaPharma.us

TRILURON is a registered trademark of Fidia Farmaceutici S.p.A., Abano Terme, Italy.
© 2023 Fidia Pharma USA Inc, Florham Park, NJ 07932
This site is intended for use by US residents only. Last Update: April 2020

References

1. TRILURON® [package insert]. Abano Terme, Italy: Fidia Farmaceutici; July 2019. 2. TRILURON® [patient information]. Fidia Farmaceutici, July 2019. 3. Deshpande BR, Katz JN, Solomon DH, et al. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthritis Care Res. 2016;68(12):1743-1750. 4. American Academy of Orthopaedic Surgeons. About Your Knee. https://orthoinfo.aaos.org/globalassets/pdfs/about-your-knee.pdf. Accessed January 24, 2020. 5. American Academy of Orthopaedic Surgeons. Arthritis of the Knee. https://orthoinfo.aaos.org/en/diseases--conditions/arthritis-of-the-knee. Accessed January 24, 2020. 6. Parmet S, Lynm C, Glass RM. JAMA patient page. Osteoarthritis of the knee. JAMA. 2003;289(8):1068. 7. Arthritis Foundation. Osteoarthritis. https://www.arthritis.org/diseases/osteoarthritis. Accessed January 24, 2020. 8. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115-26.